Orthogonal SARS-CoV-2 Serological Assays Enable Surveillance of Low-Prevalence Communities and Reveal Durable Humoral Immunity
Tyler J. Ripperger, Jennifer L. Uhrlaub, Makiko Watanabe, Rachel Wong, Yvonne Castaneda, Hannah A. Pizzato, Mallory R. Thompson, Christine M. Bradshaw, Craig C. Weinkauf, Christian Bime, Heidi L. Erickson, Kenneth S. Knox, Billie Bixby, Sairam Parthasarathy, Sachin Chaudhary, Bhupinder Natt, Elaine Cristan, Tammer El Aini, Franz Rischard, Janet Campion, Madhav Chopra, Michael Insel, Afshin Sam, James Knepler, Andrew P. Capaldi, Catherine Spier, Michael D. Dake, Taylor Edwards, Matthew E. Kaplan, Serena Jain Scott, Cameron Hypes, Jarrod Mosier, David T. Harris, Bonnie LaFleur, Ryan Sprissler, Janko Nikolich‐Žugich, Deepta Bhattacharya
Topics & Concepts
SerologyBiologyImmunityImmunologyHumoral immunityVirologyCoronavirus disease 2019 (COVID-19)Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Antibody2019-20 coronavirus outbreakImmune systemMedicineDiseaseInternal medicineInfectious disease (medical specialty)OutbreakSARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 epidemiological studies